Your browser is no longer supported. Please, upgrade your browser.
ZOM Zomedica Pharmaceuticals Corp. daily Stock Chart
Zomedica Pharmaceuticals Corp.
Index- P/E- EPS (ttm)-0.25 Insider Own35.70% Shs Outstand113.40M Perf Week-10.71%
Market Cap44.04M Forward P/E- EPS next Y-0.06 Insider Trans- Shs Float45.97M Perf Month25.86%
Income-24.40M PEG- EPS next Q-0.02 Inst Own1.90% Short Float0.59% Perf Quarter55.80%
Sales- P/S- EPS this Y-93.10% Inst Trans-44.56% Short Ratio1.08 Perf Half Y-40.26%
Book/sh-0.04 P/B- EPS next Y62.50% ROA-381.50% Target Price1.00 Perf Year-78.54%
Cash/sh0.05 P/C7.59 EPS next 5Y- ROE- 52W Range0.20 - 2.10 Perf YTD-68.42%
Dividend- P/FCF- EPS past 5Y7.00% ROI- 52W High-81.50% Beta-
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin- 52W Low94.59% ATR0.04
Employees27 Current Ratio4.10 Sales Q/Q- Oper. Margin- RSI (14)54.15 Volatility11.05% 12.13%
OptionableNo Debt/Eq- EPS Q/Q50.30% Profit Margin- Rel Volume0.47 Prev Close0.41
ShortableYes LT Debt/Eq- EarningsAug 08 Payout- Avg Volume251.62K Price0.39
Recom2.00 SMA20-1.20% SMA5024.79% SMA200-33.26% Volume117,263 Change-4.57%
Sep-18-19 01:39PM  Do Insiders Own Shares In Zomedica Pharmaceuticals Corp. (CVE:ZOM)? Simply Wall St.
Sep-17-19 06:55AM  Zomedica names Dr. Stephanie Morley President GlobeNewswire
Sep-11-19 09:09AM  PCG Research Announces Publication of Report Covering Zomedica Pharmaceuticals Corp. Newsfile +17.33%
09:00AM  Zomedica to Present at the Fall Investor Summit on Monday, September 16 in New York City ACCESSWIRE
Sep-03-19 06:55AM  Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference GlobeNewswire
Aug-19-19 06:55AM  Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors GlobeNewswire
Aug-13-19 08:00AM  Zomedica Inc. Prepares to Launch Veterinarian Diagnostic Device, TRUFORMA(TM); Has Potential to Change Diagnostic Landscape in Animal Health (NYSE American: ZOM) ACCESSWIRE
Aug-08-19 04:08PM  Zomedica Announces Second Quarter 2019 Financial Results GlobeNewswire
Aug-07-19 06:55AM  Zomedica Announces TRUFORMA Assay Updates and R&D Expansion GlobeNewswire
Jul-25-19 06:55AM  Zomedicas Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4 GlobeNewswire
Jul-17-19 06:55AM  Zomedica Announces Initiation of a Digital Data Platform Enhancing its Diagnostic Pipeline GlobeNewswire
Jun-26-19 10:05AM  ZOM: One Instrument; Multiple Solutions Zacks Small Cap Research
Jun-13-19 06:55AM  Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform GlobeNewswire +10.20%
Jun-12-19 04:35PM  Zomedica to Present at Raymond James Life Sciences and MedTech Conference GlobeNewswire -13.05%
Jun-10-19 06:00AM  Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares GlobeNewswire +6.57%
May-21-19 06:55AM  Zomedica Announces Achievement of Product Development Milestones on its TRUFORMA Point-of-Care Diagnostic Platform GlobeNewswire +12.96%
May-10-19 05:21PM  Zomedica Announces First Quarter 2019 Financial Results GlobeNewswire +6.69%
06:00AM  Zomedica Announces Private Placement of Preferred Shares GlobeNewswire
Mar-26-19 06:00AM  Zomedica Pharmaceuticals Corp. Announces Pricing of $3 Million Underwritten Public Offering of Common Shares GlobeNewswire -43.82%
Mar-25-19 04:01PM  Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering of Common Shares GlobeNewswire -12.38%
Mar-05-19 06:55AM  Zomedica Initiates ZM-006 Pilot Efficacy Study and Provides Corporate Updates GlobeNewswire +6.77%
Feb-26-19 04:05PM  Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results GlobeNewswire
Jan-15-19 06:55AM  Zomedica Appoints Dr. Bonnie Bragdon as Vice President of Veterinary Affairs GlobeNewswire +5.36%
Jan-14-19 06:55AM  Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update GlobeNewswire -7.44%
Dec-20-18 05:23PM  Zomedica Provides Update on Pipeline Development and Announces At-The-Market Offering Program GlobeNewswire +9.32%
Dec-19-18 06:00AM  IncellDx and Zomedica Sign Diagnostic CTC Assay Development Agreement for Canine Cancer PR Newswire -13.87%
Nov-28-18 09:53AM  Qorvo, Zomedica Tie-Up to Enhance Vet Health with BAW Sensors Zacks +12.34%
Nov-27-18 06:51AM  Zomedica Signs Exclusive Agreement with Qorvo Biotechnologies for Global Veterinary Rights to Diagnostic Point-of-Care Platform GlobeNewswire -10.47%
06:50AM  Zomedica Announces $10 Million Private Offering of Common Shares GlobeNewswire
Nov-26-18 07:25AM  Analysis: Positioning to Benefit within Dominion Energy Midstream Partners, LP, Blue Capital Reinsurance, CRH Medical, Friedman Industries, CM Finance, and Zomedica Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +11.69%
Nov-13-18 04:47PM  Zomedica Pharmaceuticals Corp. Announces Third Quarter 2018 Financial Results GlobeNewswire -5.17%
Nov-12-18 04:30PM  Zomedica Pharmaceuticals Corp. to Present at Jefferies 2018 London Healthcare Conference and LD Micro Main Event XI GlobeNewswire
Oct-16-18 09:00AM  SeeThruEquity Issues Update on Zomedica Pharmaceuticals Corp. ACCESSWIRE
Sep-18-18 06:55AM  Zomedica Pharmaceuticals Corp. to Present at LD Micro NYC Summit and Cantor 2018 Global Healthcare Conference GlobeNewswire
Aug-15-18 04:15PM  Zomedica Announces 2018 Annual Meeting Results GlobeNewswire
Aug-09-18 04:01PM  Zomedica Pharmaceuticals Corp. Announces Second Quarter 2018 Financial Results GlobeNewswire
Jun-28-18 08:57PM  Zomedica Announces Interim Closing and Extension of Its Private Offering of Common Shares GlobeNewswire
Jun-25-18 05:59PM  Zomedica Joins Russell 3000 and Russell Microcap® Indexes GlobeNewswire -15.77%
Jun-19-18 06:54AM  Zomedica Provides Product Development Update GlobeNewswire
Jun-14-18 06:15PM  Zomedica Announces Changes to Commercialization Leadership Team GlobeNewswire
May-15-18 04:06PM  Zomedica Pharmaceuticals Corp. Announces First Quarter 2018 Financial Results GlobeNewswire
04:01PM  Zomedica Announces Up to $10 Million Private Offering of Common Shares GlobeNewswire
May-14-18 07:30AM  Wired News Zomedica Inks Deal with Seraph to Develop and Market Seraphs Novel Pathogen Detection System for Veterinarians ACCESSWIRE -5.00%
May-10-18 06:55AM  Zomedica Signs Agreement With Seraph Biosciences for Innovative Veterinary Point-of-Care Diagnostic GlobeNewswire
May-07-18 06:55AM  Zomedica to Present at 2018 Disruptive Growth & Healthcare Conference GlobeNewswire
Mar-26-18 09:00AM  SeeThruEquity Issues Update on Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) ACCESSWIRE
Mar-07-18 06:55AM  Zomedica to Present at 30th Annual ROTH Conference GlobeNewswire
Feb-28-18 04:11PM  Zomedica Pharmaceuticals Corp. Announces Year End 2017 Financial Results GlobeNewswire
Feb-20-18 06:55AM  Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit GlobeNewswire
Dec-01-17 09:00AM  SeeThruEquity Initiates Coverage on Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) with a Price Target of $3.24 ACCESSWIRE -6.90%
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. It has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was founded in 2015 and is headquartered in Ann Arbor, Michigan.